Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
Preclinical antitumor activity of S-222611, an oral reversible tyrosine kinase inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor 2. [electronic resource] by
- Tanaka, Hidekazu
- Hirata, Michinari
- Shinonome, Satomi
- Wada, Toru
- Iguchi, Motofumi
- Dohi, Keiji
- Inoue, Makiko
- Ishioka, Yukichi
- Hojo, Kanji
- Yamada, Tomomi
- Sugimoto, Tatsuya
- Masuno, Koichi
- Nezasa, Ken-Ichi
- Sato, Norihito
- Matsuo, Kenji
- Yonezawa, Shuji
- Frenkel, Eugene P
- Shichijo, Michitaka
Producer: 20141104
In:
Cancer science vol. 105
Availability: No items available.
|